相关实验视频
Updated: Jan 9, 2026

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
761
通过神经成像技术进行阿尔茨海默病诊断的预测建模方法
Kamlesh Kumar Pandey1, Abhay Mishra2, Ram Milan3
1Indian Institute of Technology, Patna, India.
Ageing research reviews
|December 10, 2025
概括
机器学习和深度学习通过整合神经成像和生物标志物,提供更快,更准确的阿尔茨海默病 (AD) 诊断. 这种预测建模方法克服了传统方法的时间,成本和准确性限制.
科学领域:
- 神经科学是一个神经科学.
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响认知和社会功能.
- 传统的AD诊断依赖于神经成像 (CT,MRI,PET) 和脑脊液生物标志物 (粉样蛋白-β42,陶蛋白).
- 经典的诊断方法涉及神经图像中的手动生物标志物分析,导致时间,成本和准确性方面的挑战.
研究的目的:
- 详细介绍和讨论使用机器学习 (ML) 和深度学习 (DL) 进行阿尔茨海默病诊断的预测建模.
- 突出AI整合如何解决AD诊断和决策支持中的技术挑战.
- 分析经典预测模型并评估ML/DL算法在AD检测中的性能.
主要方法:
- 利用神经成像技术和生物标志物识别来提取特征.
- 实现数据管理,预处理和各种ML和DL算法.
- 使用各种数据集和性能矩阵来评估预测模型.
主要成果:
- 机器学习和深度学习模型显示出高精度和阿尔茨海默病诊断时间缩短.
- 预测建模自动化了神经成像和生物标记数据的整合,避免了手动操纵.
- 对经典模型和ML/DL算法的分析为分类器性能,预处理和验证指标提供了洞察力.
结论:
- 使用ML和DL的AI驱动的预测建模显著提高了阿尔茨海默病的诊断.
- 这种方法克服了传统方法的局限性,提供了更高的效率和准确性.
- 这项研究强调了将先进的计算技术整合到强大的神经退行性疾病诊断中的潜力.
关键词:
阿尔茨海默病的诊断 阿尔茨海默病的诊断面临的挑战 挑战数据预处理数据预处理深度学习是一种深度学习.图像预处理 图像预处理机器学习 机器学习预测建模预测建模验证指标 (Validation Metrix) 是一个验证指标.更多相关视频
14:27Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
16.1K
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.5K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Brain Imaging
635
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
635